ID   ULK3_HUMAN              Reviewed;         472 AA.
AC   Q6PHR2; B2RXK3; B4DFT0; B4DRQ7; D3DW68; Q9NPN5; Q9UFS4;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 2.
DT   12-OCT-2022, entry version 164.
DE   RecName: Full=Serine/threonine-protein kinase ULK3;
DE            EC=2.7.11.1;
DE   AltName: Full=Unc-51-like kinase 3;
GN   Name=ULK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Amygdala, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Blood, and Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 162-472 (ISOFORM 2).
RG   The European IMAGE consortium;
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-176, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=19279323; DOI=10.1101/gad.519709;
RA   Young A.R., Narita M., Ferreira M., Kirschner K., Sadaie M., Darot J.F.,
RA   Tavare S., Arakawa S., Shimizu S., Watt F.M., Narita M.;
RT   "Autophagy mediates the mitotic senescence transition.";
RL   Genes Dev. 23:798-803(2009).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AUTOPHOSPHORYLATION,
RP   AND MUTAGENESIS OF LYS-44 AND LYS-139.
RX   PubMed=19878745; DOI=10.1016/j.yexcr.2009.10.018;
RA   Maloverjan A., Piirsoo M., Michelson P., Kogerman P., Osterlund T.;
RT   "Identification of a novel serine/threonine kinase ULK3 as a positive
RT   regulator of Hedgehog pathway.";
RL   Exp. Cell Res. 316:627-637(2010).
RN   [10]
RP   FUNCTION, AUTOPHOSPHORYLATION, INTERACTION WITH SUFU, MUTAGENESIS OF
RP   LYS-139, AND PHOSPHORYLATION AT SER-300; SER-350; SER-384 AND SER-464.
RX   PubMed=20643644; DOI=10.1074/jbc.m110.133991;
RA   Maloverjan A., Piirsoo M., Kasak L., Peil L., Osterlund T., Kogerman P.;
RT   "Dual function of UNC-51-like kinase 3 (Ulk3) in the Sonic hedgehog
RT   signaling pathway.";
RL   J. Biol. Chem. 285:30079-30090(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Serine/threonine protein kinase that acts as a regulator of
CC       Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative
CC       regulator of SHH signaling in the absence of SHH ligand: interacts with
CC       SUFU, thereby inactivating the protein kinase activity and preventing
CC       phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively
CC       regulates SHH signaling in the presence of SHH: dissociates from SUFU,
CC       autophosphorylates and mediates phosphorylation of GLI2, activating it
CC       and promoting its nuclear translocation. Phosphorylates in vitro GLI2,
CC       as well as GLI1 and GLI3, although less efficiently. Also acts as a
CC       regulator of autophagy: following cellular senescence, able to induce
CC       autophagy. {ECO:0000269|PubMed:19279323, ECO:0000269|PubMed:19878745,
CC       ECO:0000269|PubMed:20643644}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBUNIT: Interacts (via protein kinase domain) with SUFU.
CC       {ECO:0000269|PubMed:20643644}.
CC   -!- INTERACTION:
CC       Q6PHR2; Q16543: CDC37; NbExp=2; IntAct=EBI-1383475, EBI-295634;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19279323,
CC       ECO:0000269|PubMed:19878745}. Note=Localizes to pre-autophagosomal
CC       structure during cellular senescence.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q6PHR2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6PHR2-2; Sequence=VSP_038147, VSP_038148;
CC       Name=3;
CC         IsoId=Q6PHR2-3; Sequence=VSP_039925;
CC       Name=4;
CC         IsoId=Q6PHR2-4; Sequence=VSP_057411;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highest levels observed in fetal
CC       brain. In adult tissues, high levels in brain, liver and kidney,
CC       moderate levels in testis and adrenal gland and low levels in heart,
CC       lung, stomach, thymus, prostate and placenta. In the brain, highest
CC       expression in the hippocampus, high levels also detected in the
CC       cerebellum, olfactory bulb and optic nerve. In the central nervous
CC       system, lowest levels in the spinal cord.
CC       {ECO:0000269|PubMed:19878745}.
CC   -!- INDUCTION: Up-regulated during senescence.
CC       {ECO:0000269|PubMed:19279323}.
CC   -!- PTM: Autophosphorylated. Autophosphorylation is blocked by interaction
CC       with SUFU. {ECO:0000269|PubMed:20643644}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: May be due to competing donor splice site.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. APG1/unc-51/ULK1 subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB55955.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK294245; BAG57541.1; -; mRNA.
DR   EMBL; AK299380; BAG61369.1; -; mRNA.
DR   EMBL; AL117482; CAB55955.2; ALT_INIT; mRNA.
DR   EMBL; AC091230; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036117; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC056423; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CH471136; EAW99301.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99303.1; -; Genomic_DNA.
DR   EMBL; BC157884; AAI57885.1; -; mRNA.
DR   EMBL; AL360256; CAB96176.1; -; mRNA.
DR   CCDS; CCDS45305.1; -. [Q6PHR2-1]
DR   CCDS; CCDS76779.1; -. [Q6PHR2-3]
DR   PIR; T17265; T17265.
DR   RefSeq; NP_001092906.3; NM_001099436.3. [Q6PHR2-1]
DR   RefSeq; NP_001271293.2; NM_001284364.2. [Q6PHR2-3]
DR   RefSeq; NP_001271294.1; NM_001284365.2.
DR   RefSeq; XP_005254346.1; XM_005254289.2. [Q6PHR2-4]
DR   PDB; 4WZX; X-ray; 1.39 A; A=359-449.
DR   PDB; 6FDY; X-ray; 1.70 A; U=2-277.
DR   PDB; 6FDZ; X-ray; 2.55 A; U=2-277.
DR   PDBsum; 4WZX; -.
DR   PDBsum; 6FDY; -.
DR   PDBsum; 6FDZ; -.
DR   AlphaFoldDB; Q6PHR2; -.
DR   SMR; Q6PHR2; -.
DR   BioGRID; 117470; 29.
DR   IntAct; Q6PHR2; 36.
DR   STRING; 9606.ENSP00000400312; -.
DR   BindingDB; Q6PHR2; -.
DR   ChEMBL; CHEMBL5047; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q6PHR2; -.
DR   iPTMnet; Q6PHR2; -.
DR   PhosphoSitePlus; Q6PHR2; -.
DR   BioMuta; ULK3; -.
DR   DMDM; 259016166; -.
DR   EPD; Q6PHR2; -.
DR   jPOST; Q6PHR2; -.
DR   MassIVE; Q6PHR2; -.
DR   MaxQB; Q6PHR2; -.
DR   PaxDb; Q6PHR2; -.
DR   PeptideAtlas; Q6PHR2; -.
DR   PRIDE; Q6PHR2; -.
DR   ProteomicsDB; 4075; -.
DR   ProteomicsDB; 67125; -. [Q6PHR2-1]
DR   ProteomicsDB; 67126; -. [Q6PHR2-2]
DR   ProteomicsDB; 67127; -. [Q6PHR2-3]
DR   Antibodypedia; 27077; 406 antibodies from 33 providers.
DR   DNASU; 25989; -.
DR   Ensembl; ENST00000440863.7; ENSP00000400312.2; ENSG00000140474.14. [Q6PHR2-1]
DR   Ensembl; ENST00000568667.5; ENSP00000457853.1; ENSG00000140474.14. [Q6PHR2-4]
DR   Ensembl; ENST00000569437.5; ENSP00000456051.1; ENSG00000140474.14. [Q6PHR2-3]
DR   GeneID; 25989; -.
DR   KEGG; hsa:25989; -.
DR   MANE-Select; ENST00000440863.7; ENSP00000400312.2; NM_001099436.4; NP_001092906.3.
DR   UCSC; uc010ulq.3; human.
DR   UCSC; uc059llp.1; human. [Q6PHR2-1]
DR   CTD; 25989; -.
DR   DisGeNET; 25989; -.
DR   GeneCards; ULK3; -.
DR   HGNC; HGNC:19703; ULK3.
DR   HPA; ENSG00000140474; Low tissue specificity.
DR   MIM; 613472; gene.
DR   neXtProt; NX_Q6PHR2; -.
DR   OpenTargets; ENSG00000140474; -.
DR   PharmGKB; PA134908392; -.
DR   VEuPathDB; HostDB:ENSG00000140474; -.
DR   eggNOG; KOG0595; Eukaryota.
DR   GeneTree; ENSGT00940000157689; -.
DR   HOGENOM; CLU_000288_63_58_1; -.
DR   InParanoid; Q6PHR2; -.
DR   OMA; TQAVEHD; -.
DR   OrthoDB; 642235at2759; -.
DR   PhylomeDB; Q6PHR2; -.
DR   TreeFam; TF324551; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; Q6PHR2; -.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   SignaLink; Q6PHR2; -.
DR   SIGNOR; Q6PHR2; -.
DR   BioGRID-ORCS; 25989; 5 hits in 659 CRISPR screens.
DR   GenomeRNAi; 25989; -.
DR   Pharos; Q6PHR2; Tchem.
DR   PRO; PR:Q6PHR2; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q6PHR2; protein.
DR   Bgee; ENSG00000140474; Expressed in right hemisphere of cerebellum and 168 other tissues.
DR   ExpressionAtlas; Q6PHR2; baseline and differential.
DR   Genevisible; Q6PHR2; HS.
DR   GO; GO:0005776; C:autophagosome; IBA:GO_Central.
DR   GO; GO:0097542; C:ciliary tip; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0000407; C:phagophore assembly site; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:1905037; P:autophagosome organization; IBA:GO_Central.
DR   GO; GO:0006914; P:autophagy; TAS:UniProtKB.
DR   GO; GO:0090398; P:cellular senescence; TAS:UniProtKB.
DR   GO; GO:0072537; P:fibroblast activation; IMP:CACAO.
DR   GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0007224; P:smoothened signaling pathway; IDA:FlyBase.
DR   InterPro; IPR045269; Atg1-like.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR007330; MIT_dom.
DR   InterPro; IPR036181; MIT_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24348; PTHR24348; 1.
DR   Pfam; PF04212; MIT; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00745; MIT; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF116846; SSF116846; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Autophagy; Cytoplasm;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..472
FT                   /note="Serine/threonine-protein kinase ULK3"
FT                   /id="PRO_0000250150"
FT   DOMAIN          14..270
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          280..348
FT                   /note="MIT 1"
FT   DOMAIN          375..444
FT                   /note="MIT 2"
FT   ACT_SITE        137
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         20..28
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         44
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         176
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   MOD_RES         300
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:20643644"
FT   MOD_RES         350
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:20643644"
FT   MOD_RES         384
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:20643644"
FT   MOD_RES         464
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:20643644"
FT   VAR_SEQ         1..34
FT                   /note="MAGPGWGPPRLDGFILTERLGSGTYATVYKAYAK -> MQRNGSASRGLEKT
FT                   RLRLCREARIPESAFLTGLTRESWEARCWCA (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057411"
FT   VAR_SEQ         205..214
FT                   /note="EALFGQPPFA -> GETSFPCFSP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005, ECO:0000303|Ref.6"
FT                   /id="VSP_038147"
FT   VAR_SEQ         215..472
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005, ECO:0000303|Ref.6"
FT                   /id="VSP_038148"
FT   VAR_SEQ         444..445
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_039925"
FT   VARIANT         101
FT                   /note="R -> H (in dbSNP:rs34945944)"
FT                   /id="VAR_057113"
FT   VARIANT         445
FT                   /note="K -> R (in dbSNP:rs12898397)"
FT                   /id="VAR_059771"
FT   MUTAGEN         44
FT                   /note="K->R: Decreased kinase activity."
FT                   /evidence="ECO:0000269|PubMed:19878745"
FT   MUTAGEN         139
FT                   /note="K->R: Loss of kinase activity. Does not promote GLI1
FT                   nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:19878745,
FT                   ECO:0000269|PubMed:20643644"
FT   CONFLICT        47
FT                   /note="A -> S (in Ref. 1; BAG61369)"
FT                   /evidence="ECO:0000305"
FT   STRAND          13..19
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   STRAND          28..33
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   STRAND          36..47
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   HELIX           48..50
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   HELIX           53..67
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   STRAND          77..82
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   STRAND          84..92
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   HELIX           99..106
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   HELIX           111..130
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   HELIX           140..142
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   STRAND          143..150
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   TURN            177..179
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   HELIX           182..186
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   HELIX           194..208
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   HELIX           218..226
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   STRAND          235..237
FT                   /evidence="ECO:0007829|PDB:6FDZ"
FT   HELIX           241..250
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   TURN            255..257
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   HELIX           261..265
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   TURN            268..270
FT                   /evidence="ECO:0007829|PDB:6FDY"
FT   HELIX           362..369
FT                   /evidence="ECO:0007829|PDB:4WZX"
FT   TURN            370..372
FT                   /evidence="ECO:0007829|PDB:4WZX"
FT   HELIX           374..390
FT                   /evidence="ECO:0007829|PDB:4WZX"
FT   HELIX           396..416
FT                   /evidence="ECO:0007829|PDB:4WZX"
FT   HELIX           421..445
FT                   /evidence="ECO:0007829|PDB:4WZX"
SQ   SEQUENCE   472 AA;  53444 MW;  11D03E311AF36162 CRC64;
     MAGPGWGPPR LDGFILTERL GSGTYATVYK AYAKKDTREV VAIKCVAKKS LNKASVENLL
     TEIEILKGIR HPHIVQLKDF QWDSDNIYLI MEFCAGGDLS RFIHTRRILP EKVARVFMQQ
     LASALQFLHE RNISHLDLKP QNILLSSLEK PHLKLADFGF AQHMSPWDEK HVLRGSPLYM
     APEMVCQRQY DARVDLWSMG VILYEALFGQ PPFASRSFSE LEEKIRSNRV IELPLRPLLS
     RDCRDLLQRL LERDPSRRIS FQDFFAHPWV DLEHMPSGES LGRATALVVQ AVKKDQEGDS
     AAALSLYCKA LDFFVPALHY EVDAQRKEAI KAKVGQYVSR AEELKAIVSS SNQALLRQGT
     SARDLLREMA RDKPRLLAAL EVASAAMAKE EAAGGEQDAL DLYQHSLGEL LLLLAAEPPG
     RRRELLHTEV QNLMARAEYL KEQVKMRESR WEADTLDKEG LSESVRSSCT LQ
//
